NeoLife International

TINA.org investigated NeoLife, a GNLD International brand, as part of its larger investigations into unsubstantiated disease-treatment claims and atypical income claims used by MLM companies.

To read more about TINA.org’s 2023 MLM Income Claims Investigation, click here.

To read more about TINA.org’s 2017 DSA Income Claims Investigation, click here.

To read more about TINA.org’s 2016 DSA Health Claims Investigation, click here.


How We Took Action

2024
February 14

As part of its 2023 investigation into 100 MLM companies, TINA.org notifies NeoLife of its findings that the company has used atypical income claims to market its business opportunity.

2023
April 13

The FTC sends NeoLife a Notice of Penalty Offenses Concerning Substantiation putting the company on formal notice that it is unlawful to, among other things, make claims relating to the health benefits, safety, and effectiveness of products without competent and reliable scientific evidence to support them, and that disease-treatment claims must be substantiated by at least one randomized, controlled, and double-blinded human clinical trial of the product.

2021
December 18

As part of its 2017 investigation into all DSA-member companies, TINA.org sends a letter to NeoLife regarding its use of false and unsubstantiated income claims to promote its business opportunity.

2016
November 22

As part of its 2016 investigation into all DSA-member companies selling nutritional supplements, TINA.org sends a letter to GNLD International regarding its use of inappropriate health claims to market NeoLife products.


The Latest

Filters